Towards a more nuanced global mental health by White, Ross G. & Sashidharan, S. P.
  
 
 
 
 
 
White , Ross G., and Sashidharan, S. P. (2014) Towards a more nuanced 
global mental health. British Journal of Psychiatry, 204 . pp. 415-417. ISSN 
0007-1250 
 
 Copyright © 2014 Royal College of Psychiatrists 
 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
Content must not be changed in any way or reproduced in any 
format or medium without the formal permission of the copyright 
holder(s) 
 
 
When referring to this work, full bibliographic details must be given 
 
 
 
http://eprints.gla.ac.uk/93553/ 
 
 
 
  Deposited on: 20 June 2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
 1 
Towards a more nuanced Global Mental Health 
 
R.G. White & S.P. Sashidharan 
 
Dr Ross G. White coordinates the MSc Global Mental Health programme at the University of 
Glasgow, and conducts research investigating psychosocial interventions for recovery after psychosis. 
 
Dr S.P. Sashidharan is a psychiatrist based in Glasgow. 
 
Summary: The World Health Organization has made concerted efforts to scale-up mental health 
services in low and middle-income countries through the mhGAP initiative. However, an over-
reliance on scaling-up services based on those used in high-income countries may risk causing more 
harm than good. 
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The World Health Organization (WHO) has estimated that four out of five people in Low and Middle 
Income Countries [LMIC] who need services for mental, neurological and/or substance use disorders 
do not receive treatment (WHO, 2008). This has been referred to as the treatment gap; the difference 
between the level of mental health provision that is required, and the actual level of support that is 
available. In an effort to increase (or scale-up) mental health provision in LMIC, the WHO published 
two key documents: the Mental Health Gap – Action Programme (mhGAP-AP1) and the Mental 
Health Gap – Intervention Guide (mhGAP-IG2). The mhGAP-AP outlines key steps for scaling-up 
mental health services in LMIC, while the mhGAP-IG presents integrated management plans for 
priority conditions including: depression, psychosis, bipolar disorders, and epilepsy in LMIC. Whilst 
acknowledging that the WHO initiatives (along with the two Lancet series on Global Mental Health) 
have undoubtedly increased awareness about mental health difficulties in LMIC, there is a need to 
critically reflect on the strategic direction that the mhGAP initiative has taken and consider whether 
this is the most productive way to proceed. This reflection is particularly timely in light of the 
adoption of the Mental Health Action Plan 2013-20203 which has been based on global and regional 
consultations. 
 
The ubiquitous use of medication  
Contained within mhGAP-IG there are templates for ’evidence-based interventions’ that can be 
adapted for use in different countries to address a range of psychiatric, substance abuse and 
neurological disorders that are identified as priority conditions. This is in spite of there being on-going 
debate about the cross-cultural validity of psychiatric diagnoses such as depression4,5. The first line of 
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treatment recommended in many of the mhGAP-IG templates for intervention is psychotropic 
medication. It is important to consider whether there is sufficient justification for this being the case. 
Unlike physical health problems (such as polio, influenza, and HIV), the evidence for biomedical 
causes of mental illnesses (such as depression and schizophrenia) remains fairly weak6,7. There is also 
growing evidence that aligning the treatment of mental health difficulties too closely to a biomedical 
model may have potentially detrimental effects. For example, a reliance on biomedical causal 
explanations of mental health difficulties has been associated with increased prejudice, fear, and 
desire for distance from individuals diagnosed with psychiatric disorders8. Although, psychotropic 
medication can be helpful in managing distress, there are also limitations to this approach that the 
mhGAP initiative fails to address. For example, long-term use of antipsychotic medications can 
contribute to increased morbidity (including metabolic disorders and cardiovascular conditions), and 
risk of premature mortality linked to sudden cardiac death9. Research indicates that reducing or 
discontinuing the doses of antipsychotic medication in the early stages of remission from first episode 
psychosis is actually associated with superior recovery compared to maintenance treatment with 
antipsychotics10. Important questions have also been raised about the methodologies employed by 
pharmaceutical companies to evidence the effectiveness of psychotropic medication11. 
 
There is a danger that biomedical explanations of mental health difficulties and an over-reliance on 
psychotropic medication may serve to inhibit the utilization of alternative forms of support. This is an 
important issue that merits careful consideration by those involved in scaling-up services for mental 
health in LMIC. It has been argued that a lack of academic and political engagement with alternative 
non-Western perspectives about mental health problems means that Western narratives about ’mental 
illness’ dominate over local understanding12, 13. Although mhGAP-AP and mhGAP-IG both highlight 
the importance of ‘integrated’ treatment packages that include both medication and psychosocial 
interventions, there is no acknowledgement of how the availability of these interventions may inhibit 
pluralism and the use of other forms of healing and/or support. 
 
Establishing evidence-based services…or not 
 
The mhGAP initiatives highlight the importance of scaling-up ‘evidenced-based’ interventions. 
However, the financial, human and technical resources available for conducting research in LMIC to 
establish an evidence-base for mental health interventions are very limited14. Indeed, the challenges 
associated with establishing evidence-based approaches are highlighted in the following extract from 
the mhGAP-AP1(P.13):  
 
“Scaling up is defined as a deliberate effort to increase the impact of health-service 
interventions that have been successfully tested in pilot projects, so that they will benefit more 
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people…However, pilot or experimental projects are of little value until they are scaled up to 
generate a larger policy and programme impact”.  
 
On one hand, there is a tacit acknowledgement of the importance of doing pilot research to verify the 
acceptability and effectiveness of interventions, and on the other, there is an assertion that scaling-up 
needs to occur before this evaluation can take place. We propose that this reasoning is fundamentally 
flawed. A key question that needs to be addressed is whether this approach is ethical? 
 
Whilst we acknowledge the pressing need to support the mental health needs of people across the 
globe, this should not happen at the risk of causing harm. Research conducted by the WHO has 
indicated that outcomes for serious mental disorders are not superior in high-income countries (HIC) 
relative to LMIC (where populations may not have access to medication-based treatments)15. An 
examination of the academic discourse that followed the dissemination of the findings concluded that 
strenuous efforts were made to ‘preserve an image of Western superiority and Third World 
inferiority’16. If the psychiatric services that are generally offered in HIC are failing to deliver, then 
great caution should be exercised in using these as a benchmark for scaling-up similar services in 
LMIC. It has been suggested that better outcomes for complex mental health difficulties in LMIC may 
be a consequence of the multiplicity of treatment/healing options available in LMIC compared to 
HIC17. Unfortunately, the types of services advocated by the mhGAP initiatives largely mimic the 
approach to service design that is currently advocated in HIC and do not embrace medical pluralism. 
 
Services that reflect the beliefs and practices of local people  
 
One of the key limitations of the mhGAP initiatives is the lack of emphasis that is placed on the 
potential role that social and cultural factors play in mental health problems across the globe. The 
mhGAP-AP acknowledges that ‘social and cultural factors’ are examples of demand-side barriers that 
may limit individuals’ willingness to engage with mental health interventions in LMIC1, but it does 
not elaborate on how these factors should inform the development of services. We believe that the 
design, development and implementation of services to support the mental health needs of particular 
populations will need to be embedded in qualitative research that will directly inform this process and 
tailor it to the needs of local populations. This process will require the involvement of a wide range of 
stakeholders.  We are concerned that the mhGAP initiatives did not involve sufficient consultation 
with individuals with a lived experience of mental health difficulties about what constitutes good 
services for mental health in LMIC. This lack of consultation is a criticism that has been made of 
mental health services in HIC. 
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In our view, the failure of the mhGAP initiatives to recognise the limitations of the biomedical and 
institutional models of health-care undermines the validity, relevance and appropriateness of the 
approach that it advocates. We appreciate that there are inherent risks associated with managing the 
tensions between the urgency with which services need to be scaled-up, and on the other hand 
ensuring that this is done in an ecologically valid, ethical and sustainable way. The growing 
connectivity, integration, and interdependence between people across the world can create great 
opportunities for progress. But these networks of connectivity are only as good as the ideas that are 
shared. We must critically reflect on the merits of biomedical conceptualizations of mental health and 
weigh these with local perspectives and local resources (including indigenous healing, social support 
networks, rights-based organizations and family support). 
 
Looking to the future 
 
In June of 2013, the WHO adopted the Mental Health Action Plan 2013-20203. This outlines four key 
objectives including: ‘strengthening effective leadership and governance for mental health; providing 
comprehensive, integrated and responsive mental health and social care services in community-based 
settings; implementing strategies for promotion and prevention in mental health, and; strengthening 
information systems, evidence and research for mental health’. It is hoped that this plan with its global 
focus; support for the involvement of people with lived experiences of mental health problems; and 
emphasis on mental health promotion (rather than a narrow focus on mental illness) will go some way 
to facilitating greater reciprocity between HIC and LMIC in efforts to produce innovation in mental 
health services. Only by engaging in critical reflection about how mental health services are designed 
and delivered in both HIC and LMIC can we foster a Global Mental Health that is truly global. Global 
Mental Health is a worthy quest, but it is a quest that needs to be receptive to the wealth of beliefs and 
practices espoused by the diverse populations that it seeks to serve. Moving forward there is a need to 
ensure that: a more balanced exchange of knowledge occurs between HIC and LMIC; greater 
credence is given to diverse explanatory models of distress, socio-cultural influences on mental health 
are better understood, and individuals are facilitated to find meaning in their experience irrespective 
of where they are on the globe. 
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